|
|
 |
| In-Silico Drug Development |
|
|
| By V. A. Shiva |
|
 |
|
The pharmaceutical industry is under massive chaos. Over the past decade, increased 30% annual year over year spending has resulted in not the concomitant increase in new drugs being discovered. Quite the opposite! There as has been an inverse relationship. Year over year, few drugs are being discovered and approved by the FDA. Clearly, the current model of drug development cannot be sustained. In Silico Drug Development, pioneered by our work at M.I.T. on CytoSolve is leading this effort.
Check back shortly, for a detailed article on how In Silico Drug Development is going to change the world and radically reduce the cost of drug development.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
 |
|
| References |
|
|
|
|
| CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models |
 |
|
|
|
|
|
|
| A Distributed Computational Architecture for Integrating Multiple Biomolecular Pathways |
 |
|
|
|
|
|
|
|
|
|
| Medicine |
|
|
| International Center for Integrative Systems |
 |
|
|
|
|
|
|
![](../images/spacer.gif"){kind=spacer}
